A - Human Necessities – 61 – F
Patent
A - Human Necessities
61
F
A61F 9/00 (2006.01) A61K 38/16 (2006.01) A61K 39/395 (2006.01) A61M 35/00 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2358296
The invention provides methods for delivering a therapeutic or diagnostic agent to the eye of a mammal. The method involves contacting sclera with a therapeutic or diagnostic agent so as to permit its passage through the sclera into the choroidal and retinal tissues. The sclera may be contacted with a therapeutic or diagnostic agent together with a device for enhancing transport of the agent through the sclera.
L'invention concerne des méthodes d'administration d'un agent thérapeutique ou diagnostique dans l'oeil d'un mammifère. Ladite méthode consiste à mettre la sclérotique en contact avec un agent thérapeutique ou diagnostique de manière à permettre son passage à travers la sclérotique dans les tissus rétiniens et choroïdiens. La mise en contact de la sclérotique avec un agent thérapeutique ou diagnostique peut être effectuée à l'aide d'un dispositif permettant d'améliorer l'acheminement de l'agent à travers la sclérotique.
Adamis Anthony P.
Gragoudas Evangelos S.
Miller Joan W.
Massachusetts Eye And Ear Infirmary
Mbm Intellectual Property Law Llp
LandOfFree
Targeted transscleral controlled release drug delivery to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted transscleral controlled release drug delivery to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted transscleral controlled release drug delivery to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2022260